G7-18Nate

G7-18Nate is a synthetic peptide compound recognized for its specificity as an antagonist of the TrkA receptor, a high-affinity receptor for nerve growth factor (NGF). As a member of the peptide family, G7-18Nate is engineered to modulate neurotrophin signaling pathways, making it highly relevant in neurobiology and cell signaling research. Its structural design allows for selective binding to the extracellular domain of TrkA, thereby inhibiting NGF-mediated receptor activation. Due to its unique mechanism of action and peptide-based nature, G7-18Nate serves as a valuable tool for dissecting the functional roles of TrkA signaling in a variety of biological systems.

Neurotrophin signaling studies: G7-18Nate is widely used in research focused on neurotrophin pathways, particularly those involving NGF and TrkA interactions. By selectively blocking NGF binding to TrkA, the peptide enables researchers to delineate the downstream effects of TrkA-mediated signaling. This application is instrumental in clarifying the molecular mechanisms underlying neuronal survival, differentiation, and synaptic plasticity, as well as in mapping the broader landscape of neurotrophin receptor networks.

Cellular pathway analysis: In cell-based assays, the compound serves as a potent tool to inhibit TrkA-driven signaling cascades. Researchers employ it to study the consequences of TrkA inhibition on cellular processes such as proliferation, apoptosis, and neurite outgrowth. The ability to selectively disrupt TrkA activation provides a controlled experimental context for investigating the receptor's role in both normal and pathological cellular responses, facilitating the identification of critical signaling nodes and regulatory mechanisms.

Peptide-receptor interaction research: The high specificity of G7-18Nate for the TrkA receptor makes it an exemplary model for studying peptide-receptor interactions. Investigators use the compound to explore binding kinetics, affinity constants, and receptor conformational changes upon ligand engagement. Such studies advance the understanding of structure-activity relationships in peptide ligands and inform the rational design of next-generation receptor modulators.

Drug discovery and screening: As a research tool, G7-18Nate is incorporated into in vitro screening platforms aimed at identifying novel modulators of neurotrophic signaling. Its well-characterized inhibition profile allows for benchmarking the efficacy of new small molecules, peptides, or biologics targeting TrkA or related pathways. The peptide thus supports the early stages of drug discovery, providing a reference inhibitor for validation of target engagement and functional assays.

Peptide synthesis and modification studies: Beyond its biological applications, G7-18Nate is employed in peptide chemistry research, where it serves as a template for the development of analogs with enhanced stability, selectivity, or bioactivity. Researchers leverage its sequence and structure to investigate strategies for optimizing peptide therapeutics, including backbone modifications, cyclization, and conjugation approaches. These efforts contribute to the broader field of peptide engineering by expanding the repertoire of functional peptide scaffolds available for research and development.

1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

2. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

3. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

4. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die